Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
Ingiliz
P
P
Vivantes Auguste-Viktoria Klinikum, Berlin, Germany. p_ingiliz@web.de
Benhamou
Y
Y
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005234:Fatty Liver / Q000139:chemically induced* / Q000150:complications; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007333:Insulin Resistance; D008930:Mitochondria, Liver / Q000187:drug effects; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000637:Transaminases / Q000378:metabolism*
D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D000637:Transaminases